Infectious Diseases
Conference Coverage
Future HIV PrEP innovations aim to address adherence, women’s health, and combination treatments
Only about 20% of people who could benefit from PrEP use the preventative medication.
Conference Coverage
People living with HIV are a model population for vaccination
The PLWH community can still offer valuable insights into effective ways to reach out to people.
From the Journals
Study finds chronic jet lag–like body clocks in people with HIV
The mistimed circadian phase in people living with HIV is linked to later sleep onset and earlier waking and has “important potential implications...
Conference Coverage
PrEP education during STI testing could boost HIV protection
It comes down to numbers. More people seek screening for STIs compared with those who actively seek PrEP for HIV prevention.
Feature
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
Conference Coverage
Study supports banning probiotics from the ICU
The risk is particularly acute for powdered formulations, presumably because powder more easily disseminates to contaminate central venous...
From the Journals
Opt-out HIV testing in EDs can help identify undiagnosed cases
On implementation of opt-out testing, the proportion of tests performed increased from 57.9% to 69% in a study.
From the Journals
HIV prevention: Clinician attitudes may be curtailing PrEP use
The findings reflect a prevailing fear of “risk compensation” – the concern that an individual on PrEP may start to take additional compensatory...
Latest News
The right indoor relative humidity could ward off COVID
The “sweet spot” associated with reduced COVID-19 cases and deaths is 40%-60% indoor relative humidity.
Conference Coverage
HIV: Treating ‘symptom clusters’ could help improve QOL
Evidence suggests there are four main symptom clusters.
Latest News
As STDs proliferate, companies rush to market at-home test kits. But are they reliable?
The FDA wants companies to prove that home collection kits are as accurate as those used in clinics, and that samples don’t degrade during...